Bicycle Therapeutics plc

Bicycle Therapeutics plc - ADR is a biotechnology enterprise that focuses on developing new therapies. Harnessing its proprietary bicyclic peptide (Bicycle) product platform, it conducts operations worldwide, aiming to address unmet medical needs through novel treatments. Bicycle Therapeutics is in the biotechnology industry, offering expertise in drug discovery and development. It strives to reshape the therapeutic landscape through collaborations with pharma. Its Bicycle platform facilitates the creation of highly specific and versatile molecules, allowing the firm to deliver new therapies to improve patients' lives. Add BCYC stock to your eToro virtual portfolio.